GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
49.81
-2.39 (-4.58%)
Apr 29, 2026, 1:45 PM EDT - Market open
GRAIL Employees
GRAIL had 910 employees as of December 31, 2025. The number of employees decreased by 90 or -9.00% compared to the previous year.
Employees
910
Change (1Y)
-90
Growth (1Y)
-9.00%
Revenue / Employee
$161,727
Profits / Employee
-$448,737
Market Cap
2.04B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 910 | -90 | -9.00% |
| Dec 31, 2024 | 1,000 | -360 | -26.47% |
| Dec 31, 2023 | 1,360 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| RadNet | 9,276 |
| Qiagen | 5,700 |
| Sotera Health Company | 3,000 |
| NeoGenomics | 2,500 |
| OPKO Health | 2,275 |
| GeneDx Holdings | 1,300 |
| Twist Bioscience | 979 |
| Castle Biosciences | 883 |
GRAL News
- 6 days ago - GRAIL to Announce First Quarter 2026 Financial Results - PRNewsWire
- 7 days ago - GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting - PRNewsWire
- 21 days ago - Grail, Epic Plan Galleri Test Integration For 450 Health Systems - Benzinga
- 21 days ago - GRAIL Announces Integration of the Galleri® Test into Epic Electronic Health Record Platform to Expand Access Nationwide - PRNewsWire
- 25 days ago - GRAL Investors Have Opportunity to Join GRAIL, Inc. Fraud Investigation with the Schall Law Firm - Business Wire
- 4 weeks ago - Cancer Is Striking Earlier -- Superpower and GRAIL Are Partnering to Expand Early Detection - PRNewsWire
- 6 weeks ago - Grail CEO Bob Ragusa to retire, Josh Ofman named successor - Reuters
- 6 weeks ago - GRAIL Announces Retirement of CEO Bob Ragusa and Appointment of Josh Ofman, MD, MSHS, as Successor - PRNewsWire